These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14695207)

  • 1. Adenosine 5'-triphosphate-sensitive potassium channel-mediated blood-brain tumor barrier permeability increase in a rat brain tumor model.
    Ningaraj NS; Rao MK; Black KL
    Cancer Res; 2003 Dec; 63(24):8899-911. PubMed ID: 14695207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5'-triphosphate-sensitive potassium channel.
    Zhang H; Gu YT; Xue YX
    Brain Res; 2007 May; 1144():33-41. PubMed ID: 17331483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-dependent potassium channels as a target protein for modulation of the blood-brain tumor barrier.
    Ningaraj NS; Rao M; Black KL
    Drug News Perspect; 2003 Jun; 16(5):291-8. PubMed ID: 12942160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minoxidil sulfate induced the increase in blood-brain tumor barrier permeability through ROS/RhoA/PI3K/PKB signaling pathway.
    Gu YT; Xue YX; Wang YF; Wang JH; Chen X; ShangGuan QR; Lian Y; Zhong L; Meng YN
    Neuropharmacology; 2013 Dec; 75():407-15. PubMed ID: 23973310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone enhances adenosine 5'-triphosphate-sensitive potassium channel expression in the blood-brain tumor barrier in a rat brain tumor model.
    Gu YT; Zhang H; Xue YX
    Brain Res; 2007 Aug; 1162():1-8. PubMed ID: 17618607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
    Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels.
    Ningaraj NS; Rao M; Hashizume K; Asotra K; Black KL
    J Pharmacol Exp Ther; 2002 Jun; 301(3):838-51. PubMed ID: 12023511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine 5'-triphosphate-sensitive potassium channel activator induces the up-regulation of caveolin-1 expression in a rat brain tumor model.
    Gu YT; Xue YX; Zhang H; Li Y; Liang XY
    Cell Mol Neurobiol; 2011 May; 31(4):629-34. PubMed ID: 21331626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor.
    Black KL; Ningaraj NS
    Cancer Control; 2004; 11(3):165-73. PubMed ID: 15153840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model.
    Hu J; Yuan X; Ko MK; Yin D; Sacapano MR; Wang X; Konda BM; Espinoza A; Prosolovich K; Ong JM; Irvin D; Black KL
    Mol Cancer; 2007 Mar; 6():22. PubMed ID: 17359538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS
    Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models.
    Black KL; Yin D; Konda BM; Wang X; Hu J; Ko MK; Bayan JA; Sacapano MR; Espinoza AJ; Ong JM; Irvin D; Shu Y
    Brain Res; 2008 Aug; 1227():198-206. PubMed ID: 18602898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
    Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
    Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
    Liu LB; Xue YX; Liu YH; Wang YB
    J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ROS/RhoA/PI3K/PKB signaling in NS1619-mediated blood-tumor barrier permeability increase.
    Gu YT; Xue YX; Wang YF; Wang JH; ShangGuan QR; Zhang JX; Qin LJ
    J Mol Neurosci; 2012 Sep; 48(1):302-12. PubMed ID: 22581438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors.
    Yin D; Wang X; Konda BM; Ong JM; Hu J; Sacapano MR; Ko MK; Espinoza AJ; Irvin DK; Shu Y; Black KL
    Clin Cancer Res; 2008 Jun; 14(12):4002-9. PubMed ID: 18559623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone enhances calcium-activated potassium channel expression in blood-brain tumor barrier in a rat brain tumor model.
    Gu YT; Xue YX; Wang P; Zhang H; Qin LJ; Liu LB
    Brain Res; 2009 Mar; 1259():1-6. PubMed ID: 19401176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
    Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-activated potassium channel activator down-regulated the expression of tight junction protein in brain tumor model in rats.
    Gu YT; Xue YX; Wei XY; Zhang H; Li Y
    Neurosci Lett; 2011 Apr; 493(3):140-4. PubMed ID: 21334421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ATP-sensitive potassium channel blocker glibenclamide prevents renal ischemia/reperfusion injury in rats.
    Pompermayer K; Souza DG; Lara GG; Silveira KD; Cassali GD; Andrade AA; Bonjardim CA; Passaglio KT; Assreuy J; Cunha FQ; Vieira MA; Teixeira MM
    Kidney Int; 2005 May; 67(5):1785-96. PubMed ID: 15840025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.